Michael V.
- Country
- Greece
- Department
- Oncology Department
Research Overview
Data & Insights
Has run more than one trial at 0 of 135 partner sites.
Specializations
Hematologic Malignancies
The investigator’s work centers on malignant disorders of the blood and marrow, emphasizing innovative therapeutic strategies for leukemic and lymphoid diseases.
- Acute Myeloid Leukemia
- Chronic Lymphocytic Leukemia
- Multiple Myeloma
- Diffuse Large B‑Cell Lymphoma
- Follicular Lymphoma
Research includes evaluation of targeted agents, immunotherapies, and combination regimens to improve depth of response and durability.
Solid Tumor Oncology
Focused on epithelial cancers, the investigator explores precision medicine approaches across a spectrum of organ‑specific malignancies.
- Colorectal Cancer
- Non‑Small Cell Lung Cancer
- Breast Cancer
- Large B‑Cell Lymphoma
- Pancreatic Cancer
Efforts aim to integrate molecular profiling with novel therapeutic agents to enhance treatment personalization.
Cardiovascular and Metabolic Disorders
The investigator addresses diseases of the circulatory system and metabolic regulation, targeting both acute events and chronic risk reduction.
- Acute Myocardial Infarction
- Atherosclerotic Cardiovascular Disease
- Heart Failure with Preserved Ejection Fraction
- Atrial Fibrillation
- Type 2 Diabetes
- Obesity
Research emphasizes anti‑inflammatory pathways, lipid modulation, and glycemic control to mitigate cardiovascular complications.
Respiratory and Pulmonary Diseases
In the realm of lung health, the investigator evaluates therapies for chronic obstructive and restrictive airway conditions as well as vascular pulmonary disorders.
- Chronic Obstructive Pulmonary Disease
- Asthma
- Idiopathic Pulmonary Fibrosis
- Pulmonary Arterial Hypertension
- COVID‑19
Investigations include anti‑eosinophilic agents, antifibrotic compounds, and immune modulators aimed at preserving lung function.
Autoimmune and Inflammatory Conditions
Specializing in immune‑mediated gastrointestinal and systemic diseases, the investigator explores disease‑modifying treatments to achieve sustained remission.
- Crohn’s Disease
- Ulcerative Colitis
- Primary Biliary Cholangitis
- Systemic Lupus Erythematosus
- Discoid Lupus Erythematosus
Efforts focus on cytokine inhibition, gut‑specific biologics, and novel oral agents to control inflammation.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.